Literature DB >> 28763430

The Usefulness of Individual-Level HIV Surveillance Data to Initiate Statewide HIV Partner Services: Experiences From Hawaii and New Mexico.

John Beltrami1, Andrew Gans, Michelle Wozniak, John Murphy, Benjamin Puesta, Daphne Kennebrew, Mary Angie Allen, Kevin OʼConnor.   

Abstract

CONTEXT: Partner services are a broad array of services that should be offered to persons with human immunodeficiency virus (HIV) and that are based on a process through which HIV-infected persons are interviewed to elicit information about their sex and needle-sharing partners. Human immunodeficiency virus testing of partners can result in a high yield of newly diagnosed HIV positivity, but despite this yield and the benefits of partners knowing their exposures and HIV status, partner services are often not conducted.
OBJECTIVE: We sought to determine the newly diagnosed HIV positivity and benefits to 2 health departments that conducted demonstration projects that focused on statewide HIV partner services.
DESIGN: The main sources of information used for this case study analysis included the health department funding applications, progress reports and final reports submitted to the Centers for Disease Control and Prevention, and records of communications between Centers for Disease Control and Prevention and the health departments. Required quantitative reporting included the number of partners tested and the number of partners with newly diagnosed confirmed HIV infection. Required qualitative reporting included how health departments benefited from their demonstration project activities.
SETTING: Hawaii and New Mexico. PARTICIPANTS: Sex and needle-sharing partners of persons who were newly diagnosed with HIV infection. INTERVENTION: The use of HIV surveillance data to initiate statewide HIV partner services. MAIN OUTCOME MEASURE: Newly diagnosed HIV positivity.
RESULTS: During 2012-2015, the newly diagnosed HIV positivity among partners was 18% (78/427): 16% (17/108) in Hawaii and 19% (61/319) in New Mexico. The health departments benefited from improved collaborations among HIV prevention program and surveillance staff and among the health departments, providers, and AIDS service organizations.
CONCLUSIONS: Hawaii and New Mexico each achieved a high newly diagnosed HIV positivity and benefited from improved local collaborations. As a result of the success of these projects, both health departments have continued the activities since the end of category C funding by securing alternative funding sources.

Entities:  

Mesh:

Year:  2018        PMID: 28763430      PMCID: PMC5792370          DOI: 10.1097/PHH.0000000000000643

Source DB:  PubMed          Journal:  J Public Health Manag Pract        ISSN: 1078-4659


  17 in total

1.  Applying Public Health Principles to the HIV Epidemic--How Are We Doing?

Authors:  Thomas R Frieden; Kathryn E Foti; Jonathan Mermin
Journal:  N Engl J Med       Date:  2015-12-01       Impact factor: 91.245

2.  Shifting the paradigm: using HIV surveillance data as a foundation for improving HIV care and preventing HIV infection.

Authors:  Patricia Sweeney; Lytt I Gardner; Kate Buchacz; Pamela Morse Garland; Michael J Mugavero; Jeffrey T Bosshart; R Luke Shouse; Jeanne Bertolli
Journal:  Milbank Q       Date:  2013-07-08       Impact factor: 4.911

3.  HIV partner services are associated with timely linkage to HIV medical care.

Authors:  Angelica Bocour; Tamar C Renaud; Chi-Chi N Udeagu; Colin W Shepard
Journal:  AIDS       Date:  2013-11-28       Impact factor: 4.177

4.  The HIV treatment cascade--a new tool in HIV prevention.

Authors:  Thomas P Giordano
Journal:  JAMA Intern Med       Date:  2015-04       Impact factor: 21.873

5.  Prevention of HIV-1 infection with early antiretroviral therapy.

Authors:  Myron S Cohen; Ying Q Chen; Marybeth McCauley; Theresa Gamble; Mina C Hosseinipour; Nagalingeswaran Kumarasamy; James G Hakim; Johnstone Kumwenda; Beatriz Grinsztejn; Jose H S Pilotto; Sheela V Godbole; Sanjay Mehendale; Suwat Chariyalertsak; Breno R Santos; Kenneth H Mayer; Irving F Hoffman; Susan H Eshleman; Estelle Piwowar-Manning; Lei Wang; Joseph Makhema; Lisa A Mills; Guy de Bruyn; Ian Sanne; Joseph Eron; Joel Gallant; Diane Havlir; Susan Swindells; Heather Ribaudo; Vanessa Elharrar; David Burns; Taha E Taha; Karin Nielsen-Saines; David Celentano; Max Essex; Thomas R Fleming
Journal:  N Engl J Med       Date:  2011-07-18       Impact factor: 91.245

6.  Update on the Epidemiology and Prevention of HIV/AIDS in the United States.

Authors:  Amanda D Castel; Manya Magnus; Alan E Greenberg
Journal:  Curr Epidemiol Rep       Date:  2015-06

7.  Positive Charge: Filling the Gaps in the U.S. HIV Continuum of Care.

Authors:  Cathy Maulsby; Vignetta Charles; Suzanne Kinsky; Maura Riordan; Kriti Jain; David Holtgrave
Journal:  AIDS Behav       Date:  2015-11

8.  Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy.

Authors:  Alison J Rodger; Valentina Cambiano; Tina Bruun; Pietro Vernazza; Simon Collins; Jan van Lunzen; Giulio Maria Corbelli; Vicente Estrada; Anna Maria Geretti; Apostolos Beloukas; David Asboe; Pompeyo Viciana; Félix Gutiérrez; Bonaventura Clotet; Christian Pradier; Jan Gerstoft; Rainer Weber; Katarina Westling; Gilles Wandeler; Jan M Prins; Armin Rieger; Marcel Stoeckle; Tim Kümmerle; Teresa Bini; Adriana Ammassari; Richard Gilson; Ivanka Krznaric; Matti Ristola; Robert Zangerle; Pia Handberg; Antonio Antela; Sris Allan; Andrew N Phillips; Jens Lundgren
Journal:  JAMA       Date:  2016-07-12       Impact factor: 56.272

9.  HIV infection among partners of HIV-infected black men who have sex with Men - North Carolina, 2011-2013.

Authors:  Philip J Peters; Cindy Gay; Steve Beagle; Anupama Shankar; William M Switzer; Lisa B Hightow-Weidman
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2014-02-07       Impact factor: 17.586

10.  HIV prevention in clinical care settings: 2014 recommendations of the International Antiviral Society-USA Panel.

Authors:  Jeanne M Marrazzo; Carlos del Rio; David R Holtgrave; Myron S Cohen; Seth C Kalichman; Kenneth H Mayer; Julio S G Montaner; Darrell P Wheeler; Robert M Grant; Beatriz Grinsztejn; N Kumarasamy; Steven Shoptaw; Rochelle P Walensky; Francois Dabis; Jeremy Sugarman; Constance A Benson
Journal:  JAMA       Date:  2014 Jul 23-30       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.